Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roxas Accepts Price Controls in Cheaper Medicines Bill (Phillipines)

This article was originally published in PharmAsia News

Executive Summary

A large obstacle has been removed clearing the path for legislation designed to allow greater access to affordable medications in the Philippines. Previously, Senator Manual Roxas II had been one of the biggest opponents to a provision in the Philippines House version of the bill that would set up market controls to reduce drug prices. Mr. Roxas' now says that price controls could provide needed insurance if market competition from generics and imports is not sufficient to lower drug prices. Roxas' concession could prove a major leg up for the bill if it passes its readings in the House and the Senate and goes to a bicameral conference. (Click here for more - May Require Free Registration





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts